3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
13
Triple Negative Breast Neoplasms
5
Neoplasm Metastasis
3
Urinary Bladder Neoplasms
2
Urethral Neoplasms
1
Ureteral Neoplasms
1
Sarcoma
1
Refractory Solid Tumors
1
Liposarcoma
1
HR+HER2- Breast Cancer
1
Carcinoma, Transitional Cell
1
Interventions
selinexor
1
pazopanib
1
Proton Therapy
1
Ifosfamide
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hemangioendothelioma, Epithelioid
×
eribulin
×
90 days
×
Clear all
No trials found.